产品封面图
文献支持

3258-07-9 1-((2S,3R,4S,5R)-3,4

-二羟基-5-(羟甲基)四氢呋.喃-2-基)嘧啶-2,4(1H,3H)-二酮
收藏
  • ¥1524.80
  • 康瑞纳
  • 进口/国产
  • LC16647
  • 2025年07月15日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件

      Sealed in dry,2-8°C

    • 保质期

      2年

    • 英文名

      1-(a-D-ribofuranosyl)uracil

    • 库存

      999

    • 供应商

      北京康瑞纳生物科技有限公司

    • CAS号

      3258-07-9

    • 规格

      250mg

    3258-07-9 1-((2S,3R,4S,5R)-3,4-二羟基-5-(羟甲基)四氢呋.喃-2-基)嘧啶-2,4(1H,3H)-二酮 产品编号:LC16647 产品名称:3258-07-9 1-((2S,3R,4S,5R)-3,4-二羟基-5-(羟甲基)四氢呋.喃-2-基)嘧啶-2,4(1H,3H)-二酮 CAS:3258-07-9 英文名称:1-(a-D-ribofuranosyl)uracil 分子式:C9H12N2O6 分子量:244.20 沸点:0保存条件:Sealed in dry,2-8°C 纯度:95%
    推荐产品
    A3026 雄诺龙 521-18-6
    A2313 脂多糖 LPS
    A3194 2,3,5氯化三苯基四氮唑 TTC 298-96-4
    A2176 异丙基-β-D-硫代半乳糖苷 IPTG 367-93-1
    A2462 噻唑蓝 MTT) 298-93-1
    A2189 .酸卡那霉素 25389-94-0
    A1281 氨苄青霉素 69-53-4
    A1238 牛血清白蛋白Ⅴ 牛白V 9048-46-8
    A2015 .酸庆大霉素 1405-41-0
    A2275 盐酸左氧氟沙星 177325-13-2
    A3158 甘油三酯 538-24-9
    A2827 独脚金内酯 76974-79-3
    A1619 刀豆蛋白A IV ConA 11028-71-0
    A1607 胶原酶Ⅰ 9001-12-1
    A2503 还原型辅酶Ⅱ四钠 2646-71-1
    A3206 泰乐菌素 1401-69-0
    A3124 替米考星 108050-54-0
    A1919 恩诺沙星 93106-60-6
    A1263 氨茶碱 317-34-0
    A2952 西地那非  139755-83-2
    A2672 苯妥英钠 630-93-3
    A2027 格列美脲 93479-97-1
    A2276 左炔诺孕酮 797-63-7


    产品细节图片1
    产品细节图片2
    产品细节图片3
    更多产品请详询客服

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    In Vivo Mice The LPS-induced acute lung inflammation model Mice were randomly divided into different groups: saline group, model group (LPS), DAS treatment groups and DAS prevention groups (delivered by either intratracheal instillation or intravenous injection, respectively). The LPS group was treated with 4 μg of LPS per mouse and the saline group was given the same volume of saline. The DAS prevention groups were administered with 25 mg/kg DAS at different time interval (e.g. 1 and 6 h) before LPS challenge. Mice were sacrificed at 6 h after LPS instillation and then the BALF were collected. The DAS treatment groups were administrated with LPS and the DAS (25 mg/kg) were delivered 1 h later. Mice were sacrificed at 6 h after LPS challenge and then the BALF were collected. The BALF was collected 3 times with 0.7 mL of saline each time, and the total volume of ~2 mL was recovered. The BALF samples were centrifuged (4 °C, 1000 rpm, 15 min) and the supernatant was stored at −9799 °C for subsequent analysis. 来源文献:Wei-Ya C, Yuan-Song W, Chun-Yu L, Yu-Bin J, Fei-Fei Y, Yong-Hong
    相关实验
    • 【求助】蛋白激酶C的信号通路

      0QgIhARiAhEBCICEQEnpK+EAW1ysmF2ARWFCDdkQuFkNZ3V2bTt7Om1trY2S0nDnBVJ1tQ8TeDDi4U2EWbXCmu2XocIcaFaci3y1PFDLVfr1oJ88mwhTXMmDUnOixuzZUV+taFFlhUzNL0qbXFHZ6eXK0atcyK/ksXNPyRFf1leMjgrUgypDgGCPFijHM7H34jA70MgapJ/H0LxekQgIhARiAhEBA4gBNDcpgaWf95d7aBTa8hkuJ5ocuV1gol

    • 【共享】慢病毒载体

      6dO4eSJE3Jas6q4NMQSwSUaxrC1NYJGvtuhtL8aDF27w8N2E8mLdBcf0rqhsjzKaoZw7eEBm00bEXTnA9KI8FGQBlMeCWWqY8JHOV0NAwMDPCQW0fSjpc4Dn7h3URVZfDKNS61YsSbCCysMAYYAQ4AhIB+BTOEjnsS/4wrdapGmQG1E0tPTxXYiGtku4pk9+vTti3r16qFTp07SQ7KOiQfY/a2YPnEJzn/I2lSw6YCZG1bCq46eVGRe2aEZ8S

    • PBS缓冲液等常用缓冲溶液的配制方法

      1. 甘氨酸–盐酸缓冲液(0.05 mol/L) X毫升0.2 mol/L甘氨酸+Y毫升0.2 mol/L HCI,再加水稀释至200毫升 甘氨酸分子量 = 75.07,0.2 mol/L甘氨酸溶液含15.01克/升。 2. 邻苯二甲酸–盐酸缓冲液(0.05 mol/L) X毫升0.2 mol/L邻苯二甲酸氢钾 + 0.2 mol/L HCl,再加

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥500
    广州威佳科技有限公司
    2025年07月11日询价
    文献支持
    3258-07-9 1-((2S,3R,4S,5R)-3,4-二羟基-5-(羟甲基)四氢呋.喃-2-基)嘧啶-2,4(1H,3H)-二酮
    ¥1524.80